| Financial Year |
March 31 2023 |
| Monetary Funds |
168,253,726.25 |
| Held-for-trading Financial Assets |
301,292,465.75 |
| Notes Receivable |
26,005,067.16 |
| Accounts Receivable |
23,983,908.70 |
| Advances to Suppliers |
4,675,936.51 |
| Other Receivables |
1,352,409.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,741,779.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
337,664.25 |
| Total Current Assets |
630,118,051.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
112,118,700.52 |
| Under-construction Projects |
5,858,834.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,212,038.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,342,057.74 |
| Deferred Income Tax Assets |
1,137,066.34 |
| Other Non-Current Assets |
291,000.00 |
| Sub-Total of Non-Current Assets |
173,959,697.62 |
| Total Assets |
804,077,749.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
14,393,928.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,524,446.94 |
| Taxes Payable |
9,746,169.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,882,107.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
13,294,774.28 |
| Sub-Total of Current Liabilities |
60,446,781.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,657,200.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,542,734.70 |
| Total Liabilities |
74,989,516.50 |
| Paid-In Capital(Or Share Stock) |
288,176,273.00 |
| Capital Surplus |
300,163,366.87 |
| Surplus Reserve |
30,409,818.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
104,750,341.72 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
729,088,232.97 |
| Owner's Equity（Stockholder's Equity） |
729,088,232.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
804,077,749.47 |
